Home
Home » companies

WuXi PharmaTech

China Biotech In Review: WuXi PharmaTech Reports Another Year Of Steadily Increasing Growth

China Biotech In Review: WuXi PharmaTech Reports Another Year Of Steadily Increasing Growth
Seeking Alpha

Why WuXi PharmaTech's Earnings May Be Less Than Awesome

Why WuXi PharmaTech's Earnings May Be Less Than Awesome
Motley Fool

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
Seeking Alpha

AstraZeneca's MedImmune in China joint venture to develop inflammatory disease drug

AstraZeneca's MedImmune in China joint venture to develop inflammatory disease drug
Yahoo/AP

China Biotech In Review: WuXi Makes Deal To Develop Therapeutic Antibody Candidates

China Biotech In Review: WuXi Makes Deal To Develop Therapeutic Antibody Candidates
Seeking Alpha

1 Reason WuXi PharmaTech's Earnings Aren't So Hot

1 Reason WuXi PharmaTech's Earnings Aren't So Hot
Motley Fool

WuXi PharmaTech: ideal for both value investing and trading

WuXi PharmaTech: ideal for both value investing and trading
Emerging Money

China Biotech Week In Review: Mindray Medical Continues On Acquisition Path

China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
Seeking Alpha

WuXi PharmaTech Earnings Call Insights: Backlog Recognition, Tox Business

WuXi PharmaTech Earnings Call Insights: Backlog Recognition, Tox Business
Wall St. Cheat Sheet

WuXi PharmaTech (Cayman) Beats on Both Top and Bottom Lines

WuXi PharmaTech (Cayman) Beats on Both Top and Bottom Lines
Motley Fool